INDOCO Stock View

Indoco Remedies Ltd
stock-view-header

₹ 339

icon 3.50 | 1.04
Market Cap ₹( Cr.)
31,238.97
Proj. P/E (x)
19.48
Proj. P/BV (x)
2.68
Proj. ROE (%)
15.00
Proj EV / EBITDA (x)
--
Proj. Revenue ( Cr.)
18,377.40

Stock View

BUY

Last Updated On.
24-Sep-2023
 

The average score for Indoco Remedies Ltd stands at 7 against 5, three months back.

Indoco Remedies Limited is an India-based manufacturer of pharmaceutical products. The Company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The Company offers medicines in multiple therapeutic categories, such as diabetology, respiratory, stomatology, women's health, nutritional products, gastroenterology, cardiology, metabolic disorders and primary care medicine. Its products/brands include Cyclopam, Sensodent-K, Karvol Plus, Sensoform, Cital UTI, Kidodent, Rexidin M, Lignox A, Dentogel, Aloja, Homide, Renolen, Noxa, Dexoren - S, Aloja M, ATM, Febrex Plus, Sensodent-KF, SM Fibro, MCBM 69, Cal Aid, Snowdent, Dropizin, Zincoren, Coloferrin, Bfloren, RR Sensoform Dental, Mofloren-D, and Tuspel among others. The Company caters to both domestic and international markets. Its subsidiaries include Xtend Industrial Designers and Engineers Pvt Ltd, Indoco Remedies Czech sro, and Indoco Remedies UK Limited.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.


Technical Data

50 DMA(₹)
330.58
100 DMA(₹)
332.20
200 DMA(₹)
344.10
52 Weeks Range
307.00     423.10

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required